Clorox Q2 EPS Misses 2.8% Even as Sales Top $1.67B, International Grows 7%
Clorox posted Q2 adjusted EPS of $1.39, missing estimates by 2.8%, while net sales of $1.67B beat consensus by 2.5% as both top and bottom lines declined year over year. International segment sales rose 7% (5% organic), with EBIT up 48% to $31M; Household sales fell 6%.
1. Q2 Financial Results
Clorox delivered adjusted earnings of $1.39 per share in the second quarter, missing the consensus by 2.8%. Net sales reached $1.67 billion, beating estimates by 2.5%, although both revenues and profits declined year over year.
2. International Segment Strength
The International segment achieved a 7% increase in net sales, driven by favorable price mix, positive foreign exchange and a 5% rise in organic volumes. Segment EBIT surged 48% to $31 million, well above prior forecasts.
3. Mixed Performance in Other Segments
The Health & Wellness unit grew 2% in sales and maintained robust EBIT of $190 million, while the Household segment saw a 6% drop in net sales and reported $22 million in EBIT. The Lifestyle division experienced a 5% sales decline and EBIT fell 54% to $72 million.
4. Strategic Initiatives and Outlook
Clorox continues to implement its ERP upgrade and digital transformation under the IGNITE strategy to enhance execution and value creation. Management is focusing on innovation and operational efficiency to navigate a dynamic macroeconomic environment.